Evaluation of thymus morphology and serum cortisol concentration as indirect biomarkers to detect low-dose dexamethasone illegal treatment in beef cattle

BMC Veterinary Research

Franco Mutinelli¹  Giandomenico Pozza¹  Roberto Stella¹  Letizia Moro¹  Giancarlo Biancotto¹  Annalisa Stefani¹  Katia Capello¹  Marta Vascellari¹ 

[1] Istituto Zooprofilattico Sperimentale delle Venezie, viale dell’Università 10, 35020, Legnaro, PD, Italy

关键词: Thymus;    Dexamethasone;    Cortex/medulla ratio;    Cortisol;    Indirect biomarker;    Beef cattle;   

Others  :  1119758
DOI  :  10.1186/1746-6148-8-129

 received in 2012-02-21, accepted in 2012-07-19,  发布年份 2012

【 摘 要 】

Background

Corticosteroids are illegally used in several countries as growth promoters in veal calves and beef cattle, either alone or in association with sex steroids and β-agonists, especially at low dosages and primarily through oral administration, in order to enhance carcasses and meat quality traits. The aim of the present study is to evaluate the reliability of the histological evaluation of the thymus, as well as the serum cortisol determination, in identifying beef cattle, treated with two different dexamethasone-based growth-promoting protocols and the application of different withdrawal times before slaughter.

Results

Our findings demonstrate that low dosages of dexamethasone (DXM), administered alone or in association with clenbuterol as growth promoter in beef cattle, induce morphologic changes in the thymus, resulting in increase fat infiltration with concurrent cortical atrophy and reduction of the cortex/medulla ratio (C/M). In fact, the C/M value was significantly lower in treated animals than in control ones, with both the protocols applied. The cut off value of 0.93 for the cortex/medulla ratio resulted to be highly effective to distinguish control and treated animals. The animals treated with DXM showed inhibition of cortisol secretion during the treatment period, as well as at the slaughterhouse, 3 days after treatment suspension. The animals treated with lower doses of DXM in association with clenbuterol, showed inhibition of cortisol secretion during the treatment period, but serum cortisol concentration was restored to physiological levels at slaughterhouse, 8 days after treatment suspension.

Conclusions

The histological evaluation of thymus morphology, and particularly of the C/M may represent a valuable and reproducible method applicable to large-scale screening programs, due to the easy sampling procedures at slaughterhouse, as well as time and cost-saving of the analysis. Serum cortisol determination could be considered as an useful in vivo biomarker of dexamethasone illegal treatment in beef cattle during the fattening period, whilst it does not appear to be a good biomarker at the slaughterhouse, since the protocol of DXM administration, as well as the withdrawal period could affect the reliability of the method.

【 授权许可】

   
2012 Vascellari et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Renaville R, Massart S, Lognay G, Devolder A, Sneyers M, Marlier M, Severing M, Burny A, Portetelle D: Influence of a hormonal preparation containing glucocorticoids (dexamethasone esters), progestagen (chlormadinone acetate) and oestrogen (ethinyl oestradiol) on testosterone, insulin-like growth factor-1 (IGF-1), IGF-binding proteins and spermatogenic cells in finishing bulls. Anim Product 1994, 59:189-196.
• [2]Gottardo F, Brscic M, Pozza G, Ossensi C, Costiero B, Marin A, Cozzi G: Administration of dexamethasone per os in finishing bulls. I. Effects on productive traits, meat quality and cattle behaviour as indicator of welfare. Animal 2008, 2:1073-1079.
• [3]Meyer HH: Biochemistry and physiology of anabolic hormones used for improvement of meat production. Acta Pathol Microbiol Immunol Scandinavia 2001, 109:1-8.
• [4]Council Directive. Council Directive 96/23/EC of 29 April 1996 on measures to monitor certain substances and residues thereof in live animals and animal products and repealing Directives 85/358/EEC and 86/469/EEC and Decisions 89/187/EEC and 91/664/EEC. OJ EC L 125:10–31, 23.5; 1996.
• [5]Commission Regulation. Commission Regulation (EU) N. 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin. OJ EC L 15:1–72, 20.1.2010; 2010.
• [6]Courtheyn D, Le Bizec B, Brambilla G, De Brabander HF, Cobbaert E, Van De Wiele Vercammen J, De Wasch K: Recent developments in the use and abuse of growth promoters. Anal Chim Acta 2002, 473:71-82.
• [7]Biolatti B, Bollo E, Cannizzo FT, Zancanaro G, Tarantola M, Dacasto M, Cantiello M, Carletti M, Biolatti PG, Barbarino G: Effects of low-dose dexamethasone on thymus morphology and immunological parameters in veal calves. J Vet Med A 2005, 52:202-208.
• [8]Gardini G, Del Boccio P, Colombatto S, Testore G, Corpillo D, Di Ilio C, Urabani A, Nebbia C: Proteomic investigation in the detection of the illicit treatment of calves with growth-promoting agents. Proteomics 2006, 6:2813-2822.
• [9]Toffolatti L, Rosa Gastaldo L, Patarnello T, Romualdi C, Merlanti R, Montesissa C, Poppi L, Castagnaro M, Bargelloni L: Expression analysis of androgen-responsive genes in the prostate of veal calves treated with anabolic hormones. Domest Anim Endocrinol 2006, 30:38-55.
• [10]Reiter M, Walf VM, Christians A, Pfaffl MW, Meyer HH: Modification of mRNA expression after treatment with anabolic agents and the usefulness for gene expression-biomarkers. Anal Chim Acta 2007, 586:73-81.
• [11]Courant F, Pinel G, Bichon E, Monteau F, Antignac JP, Le Bizec B: Development of a metabolomic approach based on liquid chromatography-high resolution mass spectrometry to screen for clenbuterol abuse in calves. Analyst 2009, 134:1637-1646.
• [12]Stella R, Biancotto G, Krogh M, Angeletti R, Pozza G, Sorgato MC, James P, Andrighetto I: Protein expression changes in skeletal muscle in response to growth promoter abuse in beef cattle. J Proteome Res 2011, 10:2744-2757.
• [13][http://www.salute.gov.it] webciteMinistero della Salute. Relazione finale. Piano Nazionale Residui 2009, Roma, Italy; 2009, 1-63.
• [14]Vascellari M, Pozza G, Poppi L, Capello K, Angeletti R, Ravarotto L, Andrighetto I, Mutinelli F: Evaluation of indirect biomarkers of corticosteroids use as illegal growth promoters in beef cattle. Vet Rec 2008, 163:147-152.
• [15]Cannizzo FT, Capra P, Divari S, Ciccotelli V, Biolatti B, Vincenti M: Effects of low-dose dexamethasone and prednisolone long term administration in beef calf: chemical and morphological investigation. Anal Chim Acta 2011, 700:95-104.
• [16]Council Directive Council Directive 86/609/EEC of 24 November 1986 on the approximation of laws, regulations and administrative provisions of the Member States regarding the protection of animals used for experimental and other scientific purposes. OJ EEC L 358:1–28, 18.12.1986. 1986.
• [17]Decreto Legislativo 27-1-1992 n. 116. Attuazione della direttiva n. 86/609/CEE in materia di protezione degli animali utilizzati a fini sperimentali o ad altri fini scientifici. GURI 18 febbraio 1992, n. 40, S.O.. 1992.
• [18]Commission Decision of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results (2002/657/EC). OJ EC L 221:8–36, 17.8.2002. 2002.
• [19]Bozzetta E, Pezzolato M, Maurella C, Varello K, Richelmi GB, Draisci R, Ferranti C, D’Angelo A, Caramelli M: Development of an enhanced histopathological approach to detect low-dose dexamethasone illicit treatment in veal calves. Food Additives and Contaminants A 2011, 28:1187-1192.
• [20]Groot MJ, Schilt R, Ossenkoppele JS, Berende PL, Haasnoot W: Combinations of growth promoters in veal calves: consequences for screening and confirmation methods. Zentralblatt für Veterinärmedizin A 2008, 45:425-440.
• [21]Vincenti M, Girolami F, Capra P, Pazzi M, Carletti M, Gardini G, Nebbia C: Study of dexamethasone urinary excretion profile in cattle by LC-MS/MS: comparison between theraputic and growth-promoting administration. J Agric Food Chem 2009, 57:1299-1306.
• [22]Vanhaecke L, Antignac JP, Courtheyn D, Le Bizec B, De Brabander H: Elimination kinetics of dexamethasone in bovine urine, hair and feces following single administration of dexamethasone acetate and phosphate esters. Steroids 2011, 76:111-117.
• [23]Cannizzo FT, Miniscalco B, Riondato F, Bollo E, Barbarino G, Giorgi P, Mazzini C, Biolatti B: Effects of anabolic and therapeutic doses of dexamethasone on thymus morphology and apoptosis in veal calves. Vet Rec 2008, 163:448-452.
• [24]Gruver AL, Sempowski GD: Cytokines, leptin, and stress-induced thymic atrophy. J Leukoc Biol 2008, 84:915-923.
• [25]Cannizzo FT, Spada F, Benevelli R, Nebbia C, Giorgi P, Brina N, Bollo E, Biolatti B: Thymus atrophy and regeneration following dexamethasone administration to beef cattle. Vet Rec 2010, 167:338-343.
• [26]Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980, 284:555-556.
• [27]Zubkova I, Mostowski H, Zaitseva M: Up-regulation of IL-7, stromal-derived factor-1 alpha, thymus-expressed chemokine, and secondary lymphoid tissue chemokine gene expression in the stromal cells in response to thymocyte depletion: implication for thymus reconstitution. J Immunol 2005, 175:2321-2330.
• [28]Wang SD, Huang KJ, Lin YS, Lei HY: Sepsis-induced apoptosis of the thymocytes in mice. J Immunol 1994, 152:5014-5021.
• [29]Valli VEO: Hematopoietic system. In Jubb, Kennedy, and Palmer’s Pathology of domestic animals. 5th edition. Edited by Maxie MG. Elsevier, Amsterdam; 2007:107-324.
• [30]Grandin T: Assessment of stress during handling and transport. J Anim Sci 1997, 75:249-257.
• [31]Odore R, D’angelo A, Badino P, Bellino C, Pagliasso S, Re G: Road transportation affects blood hormone levels and lymphocyte glucocorticoid and β adrenergic receptor concentrations in calves. Vet J 2004, 168:297-303.
• [32]Meij BP, Mol JA: Adrenocortical function. In Clinical biochemistry of domestic animals. 6th edition. Edited by Kaneko JJ, Harvey JW, Bruss ML. Academic, San Diego; 2008:605-622.
• [33]Abraham G, Allersmeier M, Gottschalk J, Schusser GF, Hoppen HO, Ungemach FR: Effects of dermal dexamethasone application on ACTH and both basal and ACTH-stimulated cortisol concentration in normal horses. J Vet Pharmacol Theriol 2009, 32:379-387.
• [34]Marin A, Pozza G, Gottardo F, Moro L, Stefani AL, Cozzi G, Brscic M, Andrighetto I, Ravarotto L: Administration of dexamethasone per os in finishing bulls: II. Effects on blood parameters used as indicators of animal welfare. Animal 2008, 2:1080-1086.